{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Bioactive compounds", "Cardiometabolic diseases", "Cardiovascular disease", "Diabetes", "Insulin resistance", "Medicinal plants", "Obesity", "RBP4"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37587250", "DateCompleted": {"Year": "2023", "Month": "09", "Day": "22"}, "DateRevised": {"Year": "2023", "Month": "09", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "08", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1007/s12012-023-09803-8"], "Journal": {"ISSN": "1559-0259", "JournalIssue": {"Volume": "23", "Issue": "9-10", "PubDate": {"Year": "2023", "Month": "Oct"}}, "Title": "Cardiovascular toxicology", "ISOAbbreviation": "Cardiovasc Toxicol"}, "ArticleTitle": "Targeting Retinol-Binding Protein 4 (RBP4) in the Management of Cardiometabolic Diseases.", "Pagination": {"StartPage": "285", "EndPage": "294", "MedlinePgn": "285-294"}, "Abstract": {"AbstractText": ["The ancient use of herbs for the treatment of various human diseases have been documented, with several scientific literatures supporting the use of medicinal plants. There is however a major concern about the phyto-constituents in the plants that performs the healing function and the mechanism by which it works for different ailments are still a research prospect. Cardiometabolic disease (CMD) is no doubt becoming more frequent globally and this is due to poor approach in therapy, contrary effects linked with intensive control, inept strategies with old drugs, inadequate control of some risk factors and lack of knowledge of the pathophysiological mechanisms that lead to this malaise. Retinol-binding protein 4 (RBP4) are predominantly secreted in the liver and adipose tissues and several researches have observed that elevation in serum levels of RBP4 often observed in obese experimental animals and human subjects causes CMD (obesity, insulin resistance, hyperlipidemia, etc.). RBP4 has gained special attention in the last 20\u00a0years in the field of metabolism research. This review aims to show research interaction of some medicinal plants targeting RBP4 in treating CMD and to encourage researchers, who are interested in CMD drug design, to focus on medicinal plants that inhibit the secretion of serum RBP4 in the adipose tissue for therapeutic approach to CMD. It also aims to identify the major bioactive compounds of plants that serves as a better and cheaper drug candidate for CMD and also study the signaling pathway which the plant material uses to regulate the metabolic consequences."], "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Sciences (Biochemistry Program), Olusegun Agagu University of Science and Technology, P. M. B. 353, Okitipupa, Nigeria. ce.oluwamodupe@oaustech.edu.ng."}], "LastName": "Oluwamodupe", "ForeName": "Cecilia", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Sciences (Biochemistry Program), Olusegun Agagu University of Science and Technology, P. M. B. 353, Okitipupa, Nigeria."}], "LastName": "Adeleye", "ForeName": "Adesola Oluwaseun", "Initials": "AO"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Cardiovasc Toxicol", "NlmUniqueID": "101135818", "ISSNLinking": "1530-7905"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "RBP4 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Retinol-Binding Proteins, Plasma"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Adipose Tissue"}, {"QualifierName": [], "DescriptorName": "Insulin Resistance"}, {"QualifierName": [], "DescriptorName": "Liver"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Obesity"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Cardiovascular Diseases"}, {"QualifierName": [], "DescriptorName": "Retinol-Binding Proteins, Plasma"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Adeleye, A. O. (2020). In vitro studies on antioxidant potential of aqueous extract of Bridelia ferruginea stem bark in brain and liver of wistar-albino rats using sodium nitroprusside as pro-oxidant. Asian Journal of Biochemistry, Genetics and Molecular Biology, 3(3), 39\u201345.", "ArticleIdList": ["10.9734/ajbgmb/2020/v3i330089"]}, {"Citation": "Al Zarzour, R. H., et al. (2018). Adipocytokine regulation and antiangiogenic activity underlie the molecular mechanisms of therapeutic effects of Phyllanthus niruri against non-alcoholic fatty liver disease. Nutrients, 10(8), 1057.", "ArticleIdList": ["10.3390/nu10081057", "6115813"]}, {"Citation": "Aly, O., Elias, T. R., Ashour, M. N., Agaibyi, M. H., Rasheed, W. I., Yassen, N. N., & Diab, Y. (2021). Antidiabetic and hepatoprotective activities of Bombax ceiba extract in obese rats with metabolic syndrome. Plant Archives, 21(1), 748\u2013756.", "ArticleIdList": ["10.51470/PLANTARCHIVES.2021.v21.S1.113"]}, {"Citation": "Bagalkotkar, G., et al. (2010). Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: A review. Journal of Pharmacy and Pharmacology, 58(12), 1559\u20131570.", "ArticleIdList": ["10.1211/jpp.58.12.0001"]}, {"Citation": "Balagopal, P., Graham, T. E., Kahn, B. B., Altomare, A., Funanage, V., & George, D. (2007). Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: Association with subclinical inflammation. Journal of Clinical Endocrinology, 92, 1971\u20131974. https://doi.org/10.1210/jc.2006-2712", "ArticleIdList": ["10.1210/jc.2006-2712"]}, {"Citation": "Berni, R., & Formelli, F. (1992). In vitro interaction of fenretinide with plasma retinol- binding protein and its functional consequences. FEBS Letters, 308, 43\u201345. https://doi.org/10.1016/0014-5793(92)81046-o", "ArticleIdList": ["10.1016/0014-5793(92)81046-o", "1386578"]}, {"Citation": "Birdee, G. S., & Yeh, G. (2010). Complementary and alternative medicine therapies for diabetes: A clinical review. Clin. Diabetes, 28, 147\u2013155.", "ArticleIdList": ["10.2337/diaclin.28.4.147"]}, {"Citation": "Blaner, W. S. (2007). STRA6, a cell-surface receptor for retinol-binding protein: The plot thickens. Cell Metabol., 5, 164\u2013166. https://doi.org/10.1016/j.cmet.2007.02.006", "ArticleIdList": ["10.1016/j.cmet.2007.02.006"]}, {"Citation": "Bonanni, B., Lazzeroni, M., & Veronesi, U. (2007). Synthetic retinoid fenretinide in breast cancer chemoprevention. Expert Review of Anticancer Therapy, 7, 423\u2013432. https://doi.org/10.1586/14737140.7.4.423", "ArticleIdList": ["10.1586/14737140.7.4.423", "17428163"]}, {"Citation": "Bouchard, P. R., Hutabarat, R. M., & Thompson, K. M. (2010). Discovery and development of therapeutic aptamers. Annual Review of Pharmacology and Toxicology, 50, 237\u2013257. https://doi.org/10.1146/annurev.pharmtox.010909.105547", "ArticleIdList": ["10.1146/annurev.pharmtox.010909.105547", "20055704"]}, {"Citation": "Brahmachari, G. (2011). Bio-flavonoids with promising antidiabetic potentials: A critical survey. Res. Signpost, 661, 187\u2013212."}, {"Citation": "Chen, J., Mangelinckx, S., Adams, A., Wang, Z., Li, W., & De Kimpe, N. (2015). Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications. Natural Products Communications, 10, 187\u2013200."}, {"Citation": "Chen, L., Lu, X., El-Seedi, H., & Teng, H. (2019). Recent advances in the development of sesquiterpenoids in the treatment of type 2 diabetes. Trends in Food Science & Technology, 88, 46\u201356.", "ArticleIdList": ["10.1016/j.tifs.2019.02.003"]}, {"Citation": "Cho, Y. M., Youn, B. S., Lee, H., Lee, N., Min, S. S., Kwak, S. H., Lee, H. K., & Park, K. S. (2006). Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care, 29, 2457\u20132461. https://doi.org/10.2337/dc06-0360", "ArticleIdList": ["10.2337/dc06-0360", "17065684"]}, {"Citation": "Choi, M. R. (2021). Inside the pathophysiological mechanisms of cardiometabolic diseases: The other pandemic to fight. European Journal of Physiology, 474, 1\u20134.", "ArticleIdList": ["10.1007/s00424-021-02658-4", "34961913"]}, {"Citation": "Cioffi, C. L., Dobri, N., Freeman, E. E., Conlon, M. P., Chen, P., Stafford, D. G., Schwarz, D. M., Golden, K. C., Zhu, L., Kitchen, D. B., Barnes, K. D., Racz, B., Qin, Q., Michelotti, E., Cywin, C. L., Martin, W. H., Pearson, P. G., Johnson, G., & Petrukhin, K. (2014). Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt disease. Journal of Medicinal Chemistry, 57, 7731\u20137757. https://doi.org/10.1021/jm5010013", "ArticleIdList": ["10.1021/jm5010013", "25210858", "4174998"]}, {"Citation": "DeFronzo, R. A., & Ferrannini, E. (1991). Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14(3), 173\u2013194.", "ArticleIdList": ["10.2337/diacare.14.3.173", "2044434"]}, {"Citation": "Delucchi, F., Berni, R., Frati, C., Cavalli, S., Graiani, G., Sala, R., Chaponnier, C., Gabbiani, G., Calani, L., Rio, D. D., et al. (2012). Resveratrol treatment reduces cardiac progenitor cell dysfunction and preventsmorpho-functional ventricular remodeling in type-1 diabetic rats. PLoS ONE, 7, e39836.", "ArticleIdList": ["10.1371/journal.pone.0039836", "22768138", "3387239"]}, {"Citation": "Dobri, N., Qin, Q., Kong, J., Yamamoto, K., Liu, Z., Moiseyev, G., Ma, J. X., Allikmets, R., Sparrow, J. R., & Petrukhin, K. (2013). A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis. Investigative Ophthalmology & Visual Science, 54, 85\u201395. https://doi.org/10.1167/iovs.12-10050", "ArticleIdList": ["10.1167/iovs.12-10050"]}, {"Citation": "El-Sayed, M. M., Ghareeb, D. A., Talat, H. A., & Sarhan, E. M. (2013). High fat diet induced insulin resistance and elevated retinol binding protein 4 in female rats; treatment and protection with Berberis vulgaris extract and vitamin A. Pakistan Journal of Pharmaceutical Sciences, 26, 1189\u20131195.", "ArticleIdList": ["24191325"]}, {"Citation": "Graham, T. E., Yang, Q., Bl\u00fcher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P. A., Smith, U., & Kahn, B. B. (2006). Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. New England Journal of Medicine, 354, 2552\u20132563. https://doi.org/10.1056/NEJMoa054862", "ArticleIdList": ["10.1056/NEJMoa054862", "16775236"]}, {"Citation": "Grant, S. J., Bin, Y. S., Kiat, H., & Chang, D. H. (2012). The use of complementary and alternative medicine by people with cardiovascular disease: A systematic review. BMC Public Health, 12, 299.", "ArticleIdList": ["10.1186/1471-2458-12-299", "22536991", "3444368"]}, {"Citation": "Guilbault, C., De Sanctis, J. B., Wojewodka, G., Saeed, Z., Lachance, C., Skinner, T. A., Vilela, R. M., Kubow, S., Lands, L. C., Hajduch, M., Matouk, E., & Radzioch, D. (2008). Fenretinide corrects newly found ceramide deficiency in cystic fibrosis. American Journal of Respiratory Cell and Molecular Biology, 38, 47\u201356. https://doi.org/10.1165/rcmb.2007-0036OC", "ArticleIdList": ["10.1165/rcmb.2007-0036OC", "17656682"]}, {"Citation": "Haider, D. G., Schindler, K., Mittermayer, F., M\u00fcller, M., Nowotny, P., Rieger, A., Luger, A., Ludvik, B., & Wolzt, M. (2007). Effect of rosiglitazone on visfatin and retinolbinding protein-4 plasma concentrations in HIV-positive patients. Clinical Pharmacology and Therapeutics, 81, 580\u2013585. https://doi.org/10.1038/sj.clpt.6100047", "ArticleIdList": ["10.1038/sj.clpt.6100047", "17235334"]}, {"Citation": "Higgins, L. S., & Depaoli, A. M. (2010). Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation. The American Journal of Clinical Nutrition, 91, 267S-272S. https://doi.org/10.3945/ajcn.2009.28449E", "ArticleIdList": ["10.3945/ajcn.2009.28449E", "19906796"]}, {"Citation": "Hu, H., Xu, M., Qi, R., Wang, Y., Wang, C., Liu, J., Luo, L., Xia, L., & Fang, Z. (2015). Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model. International Journal of Clinical and Experimental Medicine, 8, 17902\u201317911.", "ArticleIdList": ["26770384", "4694284"]}, {"Citation": "Kilicarslan, M., de Weijer, B. A., Simonyte, S. K., Aryal, P., Ter Horst, K. W., Cakir, H., Romijn, J. A., Ackermans, M. T., Janssen, I. M., & Berends., F.J., van de Laar A.W., Houdijk A.P., Kahn B.B., Serlie M.J. (2020). RBP4 increases lipolysis in human adipocytes and is associated with increased lipolysis and hepatic insulin resistance in obese women. The FASEB Journal, 34, 6099\u20136110. https://doi.org/10.1096/fj.201901979RR", "ArticleIdList": ["10.1096/fj.201901979RR", "32167208", "7317205"]}, {"Citation": "Kim, N., & Priefer, R. (2021). Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development. European Journal of Medicinal Chemistry, 226, 113856.", "ArticleIdList": ["10.1016/j.ejmech.2021.113856", "34547506"]}, {"Citation": "Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., et al. (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2224\u20132260. https://doi.org/10.1016/S0140-6736(12)61766-8", "ArticleIdList": ["10.1016/S0140-6736(12)61766-8", "23245609", "4156511"]}, {"Citation": "Lobb, A. (2009). Hepatoxicity associated with weight-loss supplements: A case for better post-marketing surveillance. World Journal of Gastroenterology., 15(14), 1786\u20131787.", "ArticleIdList": ["10.3748/wjg.15.1786", "19360927", "2668789"]}, {"Citation": "Mark, M., Ghyselinck, N. B., & Chambon, P. (2006). Function of retinoid nuclear receptors: Lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annual Review of Pharmacology and Toxicology, 46, 451\u2013480. https://doi.org/10.1146/annurev.pharmtox.46.120604.141156", "ArticleIdList": ["10.1146/annurev.pharmtox.46.120604.141156", "16402912"]}, {"Citation": "Mata, N. L., Lichter, J. B., Vogel, R., Han, Y., Bui, T. V., & Singerman, L. J. (2013). Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration. Retina, 33, 498\u2013507. https://doi.org/10.1097/IAE.0b013e318265801d", "ArticleIdList": ["10.1097/IAE.0b013e318265801d", "23023528"]}, {"Citation": "Mercader, J., Palou, A., & Bonet, M. L. (2011). Resveratrol enhances fatty acid oxidation capacity and reduces resistin and Retinol-Binding Protein 4 expression in white adipocytes. Journal of Nutritional Biochemistry, 22, 828\u2013834. https://doi.org/10.1016/j.jnutbio.2010.07.007", "ArticleIdList": ["10.1016/j.jnutbio.2010.07.007", "21109418"]}, {"Citation": "Moraes-Vieira, P. M., Yore, M. M., Dwyer, P. M., Syed, I., Aryal, P., & Kahn, B. B. (2014). RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell Metabolism, 19(3), 512\u2013526.", "ArticleIdList": ["10.1016/j.cmet.2014.01.018", "24606904", "4078000"]}, {"Citation": "Motani, A., Wang, Z., Conn, M., Siegler, K., Zhang, Y., Liu, Q., Johnstone, S., Xu, H., Thibault, S., Wang, Y., Fan, P., Connors, R., Le, H., Xu, G., Walker, N., Shan, B., & Coward, P. (2009). Identification and characterization of a non-retinoid ligand for retinol-binding protein 4 which lowers serum retinol-binding protein 4 levels in vivo. Journal of Biological Chemistry, 284, 7673\u20137680. https://doi.org/10.1074/jbc.M809654200", "ArticleIdList": ["10.1074/jbc.M809654200", "19147488", "2658061"]}, {"Citation": "Napoli, J. L. (1996). Biochemical pathways of retinoid transport, metabolism, and signal transduction. Clinical Immunology and Immunopathology, 80, S52\u2013S62. https://doi.org/10.1006/clin.1996.0142", "ArticleIdList": ["10.1006/clin.1996.0142", "8811064"]}, {"Citation": "Pamela A.N, Nankam M.B. (2021). Retinol-binding protein 4 in obesity and metabolic dysfunctions. Molecular and Cellular Endocrinology."}, {"Citation": "Pan, M. H., & WL Chang.WL, Lin- Shiau SY, Ho CT, Lin JK. (2001). Potential role of Garcinol as anti-cancer agent. Journal of Agriculture and Food Chemistry., 29(3), 1464\u20131474.", "ArticleIdList": ["10.1021/jf001129v"]}, {"Citation": "Pang, B., Zhao, L. H., Zhou, Q., Zhao, T. Y., Wang, H., Gu, C. J., et al. (2015). Application of berberine on treating type 2 diabetes mellitus. Int J Endocrinol, 2015, 12.", "ArticleIdList": ["10.1155/2015/905749"]}, {"Citation": "Perduca, M., Nicolis, S., Mannucci, B., Galliano, M., & Monaco, H. L. (2018). Human plasma retinol-binding protein (RBP4) is also a fatty acid-binding protein. Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids, 1863, 458\u2013466. https://doi.org/10.1016/j.bbalip.2018.01.010", "ArticleIdList": ["10.1016/j.bbalip.2018.01.010", "29414511"]}, {"Citation": "Pereira, A. S. P., Banegas-Luna, A. J., Pe\u00f1a-Garc\u00eda, J., P\u00e9rez-S\u00e1nchez, H., & Apostolides, Z. (2019). Evaluation of the Anti-Diabetic Activity of Some Common Herbs and Spices: Providing New Insights with Inverse Virtual Screening. Molecules, 24, 4030\u20134071. https://doi.org/10.3390/molecules24224030", "ArticleIdList": ["10.3390/molecules24224030", "31703341", "6891552"]}, {"Citation": "Prabhakar, P. K., & Doble, M. (2008). A target based therapeutic approach towards diabetes mellitus using medicinal plants. Current Diabetes Review, 4, 291\u2013308. https://doi.org/10.2174/157339908786241124", "ArticleIdList": ["10.2174/157339908786241124"]}, {"Citation": "Prasetyastuti, S., Sadewa, A. H., & Mustofa,. (2016). Effect of 7-hydroxy-2-(4-hydroxy-3-methoxy-phenyl)-chroman-4-one (Swietenia macrophylla king seed) on retinol binding protein-4 and phosphoenolpyruvate carboxykinase gene expression in type 2 diabetic rats. Rom J Diabetes Nutr Metab Dis., 23(3), 255\u2013265."}, {"Citation": "Radu, R. A., Han, Y., Bui, T. V., Nusinowitz, S., Bok, D., Lichter, J., Widder, K., Travis, G. H., & Mata, N. L. (2005). Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: A potential therapy for treatment of lipofuscin-based retinal diseases. Investigative Ophthalmology & Visual Science, 46, 4393\u20134401. https://doi.org/10.1167/iovs.05-0820", "ArticleIdList": ["10.1167/iovs.05-0820"]}, {"Citation": "Rauf, A., Imran, M., Suleria, H. A. R., Ahmad, B., Peters, D. G., & Mubarak, M. S. (2017). A comprehensive review of the health perspectives of resveratrol. Food & Function, 8, 4284\u20134305.", "ArticleIdList": ["10.1039/C7FO01300K"]}, {"Citation": "Rehman, M., Akhtar, N., & Mustafa, R. (2017). Antibacterial and antioxidant potential of stem bark extract of Bombax ceiba collected locally from South Punjab area of Pakistan. African Journal of Traditional, Complementary and Alternative Medicines, 14(2), 9\u201315.", "ArticleIdList": ["10.21010/ajtcam.v14i2.2"]}, {"Citation": "Salehi, B., Mishra, A. P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P. V. T., Martins, N., & Sharifi-Rad, J. (2018). Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines, 6, 91.", "ArticleIdList": ["10.3390/biomedicines6030091", "30205595", "6164842"]}, {"Citation": "Sarega, N., Imam, M. U., Esa, N. M., Zawawi, N., & Ismail, M. (2016). Effects of phenolic-rich extracts of Clinacanthus nutans on high fat and high cholesterol diet-induced insulin resistance. BMC Complementary and Alternative Medicine, 16, 88\u201398.", "ArticleIdList": ["10.1186/s12906-016-1049-5", "26924713", "4770701"]}, {"Citation": "Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87, 4\u201314. https://doi.org/10.1016/j.diabres.2009.10.007", "ArticleIdList": ["10.1016/j.diabres.2009.10.007", "19896746"]}, {"Citation": "Stefan, N., Hennige, A. M., Staiger, H., Machann, J., Schick, F., Schleicher, E., Fritsche, A., & Haring, H. U. (2007). High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care, 30, 1173\u20131178. https://doi.org/10.2337/dc06-2342", "ArticleIdList": ["10.2337/dc06-2342", "17259477"]}, {"Citation": "Sun, Q., Kiernan, U. A., Shi, L., Phillips, D. A., Kahn, B. B., Hu, F. B., Manson, J. E., Albert, C. M., & Rexrode, K. M. (2013). Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: A prospective analysis among women in the nurses\u2019 health study. Circulation, 127, 1938\u20131947. https://doi.org/10.1161/CIRCULATIONAHA.113.002073", "ArticleIdList": ["10.1161/CIRCULATIONAHA.113.002073", "23584360", "3741657"]}, {"Citation": "Sun, X., Zhang, Z., Ning, H., Sun, H., & Ji, X. (2017). Sitagliptin down-regulates retinol-binding protein 4 and reduces insulin resistance in gestational diabetes mellitus: A randomized and double-blind trial. Metabolic Brain Disease, 32, 773\u2013778. https://doi.org/10.1007/s11011-017-9958-7", "ArticleIdList": ["10.1007/s11011-017-9958-7", "28213841"]}, {"Citation": "Tabeshpour, J., Imenshahidi, M., & Hosseinzadeh, H. (2017). A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome. Iranian Journal of Basic Medical Sciences, 20, 557\u2013568. https://doi.org/10.22038/IJBMS.2017.8682", "ArticleIdList": ["10.22038/IJBMS.2017.8682", "28656091", "5478784"]}, {"Citation": "Testa, R., Bonfigli, A., Genovese, S., De Nigris, V., & Ceriello, A. (2016). The possible role of flavonoids in the prevention of diabetic complications. Nutrients, 8, 310.", "ArticleIdList": ["10.3390/nu8050310", "27213445", "4882722"]}, {"Citation": "The University of Edinburgh (2020). Cardiometabolic Diseases. https://www.ed.ac.uk/medicine-vet-medicine/our-research/research-themes/cardiometabolic-diseases"}, {"Citation": "Torabi, R., Ghourchian, H., Amanlou, M., & Pasalar, P. (2017). Aptamer-conjugated calcium phosphate nanoparticles for reducing diabetes risk via retinol binding protein 4 inhibition. Canadian Journal of Diabetes, 41, 305\u2013311. https://doi.org/10.1016/j.jcjd.2016.11.001", "ArticleIdList": ["10.1016/j.jcjd.2016.11.001", "28279618"]}, {"Citation": "Vasudeva, N., Yadav, N., & Sharma, S. K. (2012). Natural products: A safest approach for obesity. Chinese Journal of Integrative Medicine, 18, 473\u2013480. https://doi.org/10.1007/s11655-012-1120-0", "ArticleIdList": ["10.1007/s11655-012-1120-0", "22821661"]}, {"Citation": "Vendrame, S., Zhao, A., Merrow, T., & Klimis-Zacas, D. (2014). The Effects of Wild Blueberry Consumption on Plasma Markers and Gene Expression Related to Glucose Metabolism in the Obese Zucker Rat. Journal of Medicinal Food, 00, 1\u20136."}, {"Citation": "Veronesi, U., Mariani, L., Decensi, A., Formelli, F., Camerini, T., Miceli, R., Di Mauro, M. G., Costa, A., Marubini, E., Sporn, M. B., & De Palo, G. (2006). Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer. Annals of Oncology, 17, 1065\u20131071. https://doi.org/10.1093/annonc/mdl047", "ArticleIdList": ["10.1093/annonc/mdl047", "16675486"]}, {"Citation": "Vijayalakshmi, K., Nadhiya, K., Haripriya, D., & Ranjani, R. (2014). In silico Docking Analysis of Secondary Metabolites of Bauhinia variegata and Garcinia cambogia With Retinol Binding Protein4 as Target for Obesity. International Journal of Pharmacognosy and Phytochemical Research, 6(3), 636\u2013642."}, {"Citation": "Vinayagam, R., & Xu, B. (2015). Antidiabetic properties of dietary flavonoids: A cellular mechanism review. Nutri. Metab., 12, 60.", "ArticleIdList": ["10.1186/s12986-015-0057-7"]}, {"Citation": "Wang, Y (2014).Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4.Bioorg. Med. Chem. Lett,\u00a024\u00a0(13)\u00a0(2014), pp.\u00a02885\u20132891"}, {"Citation": "Yan, F., Sun, X., & Xu, C. (2018). Protective effects of resveratrol improve cardiovascular function in rats with diabetes. Experimental and Therapeutic Medicine, 15, 1728\u20131734.", "ArticleIdList": ["29434758"]}, {"Citation": "Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005). Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature, 436, 356\u2013362.", "ArticleIdList": ["10.1038/nature03711", "16034410"]}, {"Citation": "Yanovski, S. Z., & Yanovski, J. A. (2014). Long-term drug treatment for obesity: A systematic and clinical review. JAMA, 311, 74\u201386. https://doi.org/10.1001/jama.2013.281361", "ArticleIdList": ["10.1001/jama.2013.281361", "24231879", "3928674"]}, {"Citation": "Yao-Borengasser, A., Varma, V., Bodles, A. M., Rasouli, N., Phanavanh, B., Lee, M. J., Starks, T., Kern, L. M., Spencer, H. J., III., Rashidi, A. A., MacGehee, R. E., Jr., Fried, S. K., & Kern, P. A. (2007). Retinol binding protein 4 expression in humans: Relationship to insulin resistance, inflammation, and response to pioglitazone. Journal of Clinical Endocrinology and Metabolism, 92, 2590\u20132597. https://doi.org/10.1210/jc.2006-0816", "ArticleIdList": ["10.1210/jc.2006-0816", "17595259"]}, {"Citation": "Zabetian-Targhi, F., Mahmoudi, M. J., Rezaei, N., & Mahmoudi, M. (2015). Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseases. Advances in Nutrition, 6, 748\u2013762. https://doi.org/10.3945/an.115.008292", "ArticleIdList": ["10.3945/an.115.008292", "26567199", "4642414"]}, {"Citation": "Zakaria, Z., Othman, Z. A., Nna, V. U., & Mohamed, M. (2021). The promising roles of medicinal plants and bioactive compounds on hepatic lipid metabolism in the treatment of non-alcoholic fatty liver disease in animal models: Molecular targets. Archives of Physiology and Biochemistry. https://doi.org/10.1080/13813455.2021.1939387", "ArticleIdList": ["10.1080/13813455.2021.1939387", "34153200"]}, {"Citation": "Zanardi, S., Serrano, D., Argusti, A., Barile, M., Puntoni, M., & Decensi, A. (2006). Clinical trials with retinoids for breast cancer chemoprevention. Endocr. Relat. Canc., 13, 51\u201368. https://doi.org/10.1677/erc.1.00938", "ArticleIdList": ["10.1677/erc.1.00938"]}, {"Citation": "Zanotti, G., Marcello, M., Malpeli, G., Folli, C., Sartori, G., & Berni, R. (1994). Crystallographic studies on complexes between retinoids and plasma retinol-binding protein. Biological Chemistry, 269, 29613\u201329620. https://doi.org/10.1016/S0021-9258(18)43925-7", "ArticleIdList": ["10.1016/S0021-9258(18)43925-7"]}, {"Citation": "Zhou, Z., Chen, H., Ju, H., & Sun, M. (2017). Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: A systematic review and meta-analysis. Lipids in Health and Disease, 16, 180. https://doi.org/10.1186/s12944-017-0566-7", "ArticleIdList": ["10.1186/s12944-017-0566-7", "28931435", "5607593"]}, {"Citation": "Zhu, C., Xiao, Y., Liu, X., Han, J., Zhang, J., Wei, L., & Jia, W. (2015). Pioglitazone lowers serum retinol binding protein 4 by suppressing its expression in adipose tissue of obese rats. Cellular Physiology and Biochemistry, 35, 778\u2013788. https://doi.org/10.1159/000369737", "ArticleIdList": ["10.1159/000369737", "25634757"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "19"}, {"Year": "2023", "Month": "8", "Day": "5"}, {"Year": "2023", "Month": "9", "Day": "22", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "8", "Day": "17", "Hour": "0", "Minute": "41"}, {"Year": "2023", "Month": "8", "Day": "16", "Hour": "23", "Minute": "28"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37587250", "10.1007/s12012-023-09803-8", "10.1007/s12012-023-09803-8"]}}], "PubmedBookArticle": []}